Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,860 | 1,257 | 2,035 | 2,025 | 1,364 |
| Cost of Goods | 647 | 698 | 945 | 1,089 | 928 |
| Gross Profit | 1,213 | 559 | 1,090 | 936 | 436 |
| Operating Expenses | 8,698 | 10,079 | 10,269 | 8,803 | 8,656 |
| Operating Income | -6,838 | -8,822 | -8,234 | -7,778 | -7,292 |
| Interest Expense | 0 | 1,391 | -3,271 | -1,864 | 0 |
| Other Income | 145 | 892 | 0 | 0 | -892 |
| Pre-tax Income | -6,693 | -9,321 | -4,963 | -5,914 | -8,184 |
| Income Tax | 48 | 206 | 34 | 16 | 31 |
| Net Income Continuous | -6,741 | -9,527 | -4,997 | -5,930 | -8,215 |
| Net Income | $-6,741 | $-9,527 | $-4,997 | $-5,930 | $-8,215 |
| EPS Basic Total Ops | -0.32 | -0.46 | -0.24 | -0.28 | -0.40 |
| EPS Basic Continuous Ops | -0.32 | -0.46 | -0.24 | -0.29 | -0.40 |
| EPS Diluted Total Ops | -0.32 | -0.46 | -0.24 | -0.28 | -0.40 |
| EPS Diluted Continuous Ops | -0.32 | -0.46 | -0.24 | -0.29 | -0.40 |
| EBITDA(a) | $-6,555 | $-8,566 | $-7,862 | $-7,281 | $-6,813 |